High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia.

scientific article published on 30 July 2009

High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2009-05-223115
P698PubMed publication ID19643984
P5875ResearchGate publication ID26706635

P2093author name stringOllivier Legrand
Fanny Fava
Jean-Pierre Marie
Ruoping Tang
Simona Lapusan
Christophe Marzac
Pierre Hirsch
Irène Teyssandier
Julia Pardo
P433issue14
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
P304page(s)2993-3000
P577publication date2009-07-30
P1433published inBloodQ885070
P1476titleHigh Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia.
P478volume114

Reverse relations

cites work (P2860)
Q41170872ATF3 suppresses ESCC via downregulation of ID1.
Q35193725ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients
Q36595749Applying ecological and evolutionary theory to cancer: a long and winding road
Q35854158Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia
Q49787877Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AML.
Q90088711Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies
Q36897128Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.
Q34773992E47 regulates hematopoietic stem cell proliferation and energetics but not myeloid lineage restriction
Q92567745High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia
Q64111646High expression of ID1 facilitates metastasis in human osteosarcoma by regulating the sensitivity of anoikis via PI3K/AKT depended suppression of the intrinsic apoptotic signaling pathway
Q38913888ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro
Q54508849ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes.
Q33897586IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Q39402421Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis.
Q26998811Molecular prognostic factors in cytogenetically normal acute myeloid leukemia
Q35539865My what big eyes you have: how the Drosophila retina grows.
Q37810969Older patients with acute myeloid leukemia
Q36175739Physical and functional interaction between the ID1 and p65 for activation of NF-κB
Q38183943Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.
Q35717841Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALC
Q37954583Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics
Q34477821Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Q35904946Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.
Q34186326Regulation of the unfolded protein response by eif2Bdelta isoforms.
Q33873915Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.
Q39871283Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?
Q39103288The Id-protein family in developmental and cancer-associated pathways.
Q37895962Transcriptional and epigenetic regulation of B cell development
Q36100455miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia

Search more.